MBGPF

MOBERG PHARMA AB by MOBERG PHARMA AB (MBGPF)

About MOBERG PHARMA AB by MOBERG PHARMA AB (MBGPF)

Moberg Pharma AB is a pharmaceutical company, which engages in the development and commercialization of medical products. Its product pipeline includes MOB-015, which is a treatment for nail fungus. The company was founded by Peter Gunnar Maurits Wolpert and Marie Moberg in March 2006 and is headquartered in Bromma, Sweden.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$4.30
52 Week Low
$0.69
Market cap
36.3M
Dividend yield
0.00%
Volume
--
Avg. volume
3,893
P/E ratio
-1.49

MOBERG PHARMA AB by MOBERG PHARMA AB News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$4.30
52 Week Low
$0.69
Market cap
36.3M
Dividend yield
0.00%
Volume
--
Avg. volume
3,893
P/E ratio
-1.49